|
|
 |
|
Viewing report
|
|
|
|
Demand Analysis of U.S. Cancer Sample Prep Market
Frost & Sullivan, Nov 2011, Pages: 50
Sample Prep Automation for Tumor Specimens Facilitates Future Molecular Cancer Tests
There are tens of millions of formalin-fixed, paraffin-embedded (FFPE) specimens from patients with known clinical outcomes stored in archives in the United States. The global estimate for FFPE archive specimens is as high as xxx million. Individual libraries can be massive. For example, the Department of Pathology and Laboratory Medicine at the University of Pennsylvania owns about 600,000 FFPE specimens that have been amassed for over 70 years. The wealth of FFPE archive specimens has piqued tremendous interest for biomarker validation studies, which in turn has generated a surge in demand for FFPE sample prep solutions.
Molecular sample prep vendors have been offering kits specifically for FFPE specimens for the last three to five years, but in 2011, one vendor launched an FFPE-specific sample prep automation system. The introduction of process automation is significant in any market because it signals the brink of a market expansion that is fueled by the increased throughput automation provides.
Frost & Sullivan conducted a survey with pathologists who are the customers of the United States FFPE sample prep market and collected data specifically about their current use and future adoption plans of FFPE sample prep automation. This study provides an analysis of and conclusions based on this customer data, including the current installed base and market penetration for FFPE sample prep automation.
Furthermore, Frost & Sullivan forecasts the installed base growth rate and future market penetration for 2011 to 2016. The results strongly indicate that the current FFPE sample prep market is poised for rapid expansion within the next three years.
This demand-based analysis of the United States FFPE sample prep automation market provides evidence for the growth potential of molecular-based cancer testing from FFPE specimens and predicts the inevitable integration of molecular extraction techniques with the long FFPE legacy that exists in solid tumor diagnostics.
Key Features of This Report:
This analysis of the U.S. formalin fixed paraffin embedded (FFPE) sample prep market illuminates how the existing FFPE legacy in solid-tumor diagnostics is being transformed by advanced molecular techniques.
Customer demand data collected by Frost & Sullivan provides the foundation for a market penetration model in which the relative growth stage of both the hospital and reference lab segments is determined.
Furthermore, the adoption trend for FFPE sample prep automation is predicted by an install base forecast in clinical laboratories for 2011 to 2016. Companies that participate in the market include Qiagen, Life Technologies, and Roche Applied Sciences.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
